Clean Yield Group portfolio
Latest available portfolio: Q2 2026 · Holdings as of · Filed · in Form 13F holdings
See latest portfolio changes
$403M
Full value: $403,004,272 · USD · 30 Jun 2026Quarterly portfolio filings
Choose a quarter to see holdings and changes. Newer portfolio dates appear first.
Estimated additions and reductions require qualified adjacent-quarter disclosures and use filing-derived prices. A dash means unavailable; these estimates are not actual trade proceeds or costs.
| Quarter | Holdings | SEC-reported value | Est. additions | Est. reductions | Est. net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q3 2026 | $412,176,523 | — | — | — | 13F-HR | 28 Oct 2026, 13:51 | ||
| Q2 2026 | 394 | $403,004,272 | — | — | — | AAPL, NVDA, ASML, AVGO, CSCO | 13F-HR | 05 Aug 2026, 12:31 |
| Q1 2026 | 384 | $355,230,170 | — | — | — | AAPL, NVDA, AVGO, ASML, CSCO | 13F-HR | 14 Apr 2026, 10:28 |
| Q4 2025 | 408 | $360,238,351 | — | — | — | AAPL, NVDA, AVGO, ASML, CSCO | 13F-HR | 26 Jan 2026, 10:55 |
| Q3 2025 | 416 | $353,802,170 | — | — | — | AAPL, NVDA, AVGO, AWK, ASML | 13F-HR | 23 Oct 2025, 11:37 |
| Q2 2025 | 399 | $334,292,426 | — | — | — | AAPL, NVDA, AVGO, SFM, AWK | 13F-HR | 17 Jul 2025, 12:16 |
| Q1 2025 | 444 | $306,929,823 | — | — | — | AAPL, SFM, NVDA, AWK, UL | 13F-HR | 14 Apr 2025, 09:41 |
| Q4 2024 | 454 | $314,392,028 | — | — | — | AAPL, SFM, NVDA, AVGO, UL | 13F-HR | 13 Jan 2025, 14:24 |
| Q3 2024 | 469 | $314,573,669 | — | — | — | AAPL, SFM, UL, NVDA, AWK | 13F-HR | 07 Oct 2024, 11:33 |
| Q2 2024 | 362 | $267,708,058 | — | — | — | AAPL, SFM, UL, GSK, AWK | 13F-HR | 10 Jul 2024, 10:57 |
| Q1 2024 | 379 | $257,055,940 | — | — | — | AAPL, GSK, UL, SFM, DOC | 13F-HR | 29 May 2024, 11:39 |
| Q4 2023 | 363 | $237,411,234 | — | — | — | AAPL, UL, GSK, TAK, SFM | 13F-HR | 24 Jan 2024, 15:15 |
| Q3 2023 | 374 | $221,762,675 | — | — | — | AAPL, UL, TAK, GSK, VOD | 13F-HR | 12 Oct 2023, 14:00 |
| Q2 2023 | 401 | $242,782,830 | — | — | — | AAPL, UL, TAK, GSK, VOD | 13F-HR | 26 Jul 2023, 10:11 |
| Q1 2023 | 420 | $234,753,227 | — | — | — | AAPL, UL, TAK, GSK, DOC | 13F-HR | 26 Apr 2023, 09:50 |
| Q4 2022 | 452 | $232,814,271 | — | — | — | AAPL, UL, TAK, GSK, DOC | 13F-HR | 31 Jan 2023, 15:10 |
| Q3 2022 | 453 | $212,656,000 | — | — | — | AAPL, UL, VOD, TAK, DOC | 13F-HR | 31 Oct 2022, 11:49 |
| Q2 2022 | 416 | $240,300,000 | — | — | — | AAPL, GSK, UL, VOD, DOC | 13F-HR | 18 Jul 2022, 15:47 |
| Q1 2022 | 466 | $279,883,000 | — | — | — | AAPL, GSK, GRNB, UL, TU | 13F-HR | 25 Apr 2022, 15:49 |
| Q4 2021 | 445 | $300,542,000 | — | — | — | AAPL, GRNB, GSK, TU, UL | 13F-HR | 24 Jan 2022, 15:58 |
| Q3 2021 | 467 | $282,495,000 | — | — | — | AAPL, GRNB, CNBKA, GSK, UL | 13F-HR | 27 Oct 2021, 14:18 |
| Q2 2021 | 454 | $269,368,000 | — | — | — | AAPL, GRNB, CNBKA, GSK, UL | 13F-HR | 26 Jul 2021, 16:24 |
| Q1 2021 | 147 | $242,060,000 | — | — | — | AAPL, CNBKA, VOD, VMBS, UL | 13F-HR | 26 Apr 2021, 14:10 |
| Q4 2020 | 418 | $236,666,000 | — | — | — | AAPL, HASI, UL, TU, CNBKA | 13F-HR | 26 Jan 2021, 11:04 |
| Q3 2020 | 368 | $201,879,000 | — | — | — | AAPL, UN, HASI, VOD, TU | 13F-HR | 16 Oct 2020, 10:41 |
Showing 1-25 of 52 filings.
Manager details and filing context
- Latest 13F filing
- Q2 2026 - 05 Aug 2026
- Latest reported 13F value
- $403,004,272
- Largest 13F holdings
- AAPL NVDA ASML AVGO CSCO ANET GSK AWK PLD HASI FERG UL
+8 more
CAC IBM CRM DGX PANW NOK HUBB ECL - Manager location
- Norwich, VT
Holdings Value